4//SEC Filing
Gupta Soma 4
Accession 0000899243-21-000469
CIK 0001560241other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:22 PM ET
Size
7.7 KB
Accession
0000899243-21-000469
Insider Transaction Report
Form 4
Gupta Soma
Chief Commercial Officer
Transactions
- Award
Common Stock
2021-01-04+11,000→ 11,000 total - Award
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 totalExercise: $18.07Exp: 2031-01-04→ Common Stock (58,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 25% on January 4, 2022 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]The shares underlying this option vest as to 25% of the shares on January 4, 2022, with the remainder vesting in 36 equal installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Documents
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001807874
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:22 PM ET
- Size
- 7.7 KB